AstraZeneca will resume its COVID-19 vaccine trial in US

  • 📰 CNN Philippines
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

Drugmaker AstraZeneca will resume the trial of its experimental coronavirus vaccine in the United States, which has been on hold since September.

The company said the US Food and Drug Administration authorized the restart Thursday after reviewing all of the global safety data and concluding it was safe to resume. The trial had already resumed in other countries.

Government health officials, as well as outside experts, have said the hold is an example of how the safety process is working and protecting Americans from any potentially dangerous vaccines. Regulators wanted to check to make sure any problems could not have been caused by the vaccine. An internal AstraZeneca safety report obtained by CNN last month showed the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on Sept. 5. The woman was enrolled in the UK arm of the trial, which is run by the University of Oxford.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 13. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

First large-scale US COVID-19 vaccine trial reaches target enrollment of 30,000 participantsModerna, the first company to start US clinical trials of a COVID-19 vaccine, finished enrolling all 30,000 of its participants.
Source: CNN Philippines - 🏆 13. / 63 Read more »

Golf: No spectators for US Women's Open in Covid-19 safety move
Source: ANCALERTS - 🏆 26. / 50 Read more »

Gilead’s remdesivir gets US FDA approval for use in hospitalized COVID-19 patientsThe U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc&039;s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug
Source: inquirerdotnet - 🏆 3. / 86 Read more »

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patientsThe U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Remdesivir, given intravenously, was one of the drugs used to treat U.S. President Donald Trump during his bout with …
Source: interaksyon - 🏆 24. / 51 Read more »

US records 2nd-highest single-day rise in COVID-19 infectionsBecause they are testing more. Faster than any other country.
Source: ANCALERTS - 🏆 26. / 50 Read more »

Avigan trial in PH faces recruitment woes due to downtrend in COVID-19 casesThe clinical trial in the Philippines for anti-viral drug Avigan has hit another snag after the Department of Health reveals that hospitals are having trouble recruiting volunteer patients. Thanks to Persida It’s more of due to people realizing this pandemic is an overreaction. Don’t believe me? Read about the latest WHO infection fatality rates and just go outside and see how many people are already going out. I hope it’s not because the priority is given to the Russian and Chinese vaccines because we need all the help that we can get as early as possible.
Source: CNN Philippines - 🏆 13. / 63 Read more »